On Tuesday, February 27, 2024, Gifu University and the National Cancer Center (NCC) entered into a comprehensive partnership agreement regarding education, research, and medical cooperation. The purpose of this agreement is to enhance the quality of education, research, and medical activities related to cancer, thereby contributing to the development of academia and healthcare as well as fostering talented individuals.

At the signing ceremony, Dr. NAKAGAMA Hitoshi, NCC President, stated, "Through this agreement, it becomes possible for our center to share a seamless platform for medical device development, spanning from fundamental research to clinical implementation, along with a large-scale medical and omics data infrastructure, with researchers from Gifu University. We anticipate synergistic effects in enhancing the development and acceleration of diverse medical potentials by materializing innovative concepts held by both institutions."

President YOSHIDA Kazuhiro of Gifu University stated, "By entering into this comprehensive agreement, we will not only collaborate on clinical trials and research with the relevant departments and the University Hospital, but also promote joint research program development from basic research to clinical application. Additionally, we will engage in diverse initiatives to provide more effective treatments for cancer patients and work towards the creation and exploration of new medical possibilities.

It is expected that this newly concluded partnership agreement will enable both institutions to continue collaborating in various aspects of education, research, and healthcare, and contribute to the well-being of people in the community.